IBKS No3 SPAC

225430 · KQ · Financial Services / Asset Management

698.00KRW+16.00 (+2.35%)

Price History

Full chart

Market Stats

Previous Close682.00

Open730.00

Day Range564.00 – 820.00

52-Week Range508.00 – 6,850.00

Volume0

Market Cap3.89B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

Beta-0.78

50-Day Avg1,214.44

200-Day Avg2,126.67

About

KMPHARMACEUTICAL Co.,Ltd. engages in the manufacture, wholesale, and retail of oral care, beauty care, and other daily necessities in South Korea and internationally. The company offers toothpastes, toothbrushes, cosmetics, masks, hand cream, toothbrush and toothpaste, kids toothbrush, and baby finger toothbrush sets. It also provides children's safety gargles, baby and light wipes, wet wipes, and steam eye masks; shampoos, body washes, sun creams, moisture creams, wrinkle functional cosmetics, and hair dyes; and dehumidifiers and hand sanitizers. The company was founded in 2001 and is headquartered in Pyeongtaek-si, South Korea.

Company Details

SectorFinancial Services
IndustryAsset Management
CEOMr. Il-Mo Kang
Employees0
HeadquartersHQ 121, Pyeongtaek-si, South Korea, 075573, Korea
Websitehttps://www.kmkmp.com

Leadership

Mr. Il-Mo KangCEO & Representative Chairman · b. 1967
Mr. Brian Seung Won BaikCEO & Internal Director · b. 1984
Ms. Yeong-ae LimExecutive Director · b. 1976

Financials

Income Statement

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	-	0	0	17.30B	20.34B	22.93B	22.71B	15.63B	17.77B	14.47B	15.99B
Growth (%)	-	-	-	-	+17.55%	+12.73%	-0.97%	-31.15%	+13.68%	-18.54%	+10.47%
Cost of Revenue	-	-	-	11.51B	14.55B	16.99B	17.04B	12.41B	12.86B	10.87B	12.15B
Gross Profit	-	-	-	5.79B	5.79B	5.94B	5.66B	3.22B	4.91B	3.61B	3.84B
Gross Margin	-	-	-	33.49%	28.45%	25.91%	24.94%	20.63%	27.63%	24.91%	24.00%
Operating Expense	-	-	-	4.22B	7.31B	5.23B	4.80B	5.28B	6.01B	6.17B	6.76B
Operating Income	-21.40M	-99.19M	-88.31M	1.57B	-1.53B	712.32M	866.14M	-2.05B	-1.10B	-2.57B	-2.92B
Operating Margin	-	-	-	9.08%	-7.50%	3.11%	3.81%	-13.15%	-6.19%	-17.75%	-18.28%
EBITDA	-	-	-	-	-	-	-	-2.73B	1.02B	-2.33B	-2.28B
EBITDA Margin	-	-	-	-	-	-	-	-17.47%	5.73%	-16.11%	-14.26%
Net Income	401.58K	6.89M	14.90M	-12.33B	-902.23M	470.88M	-219.78M	-3.92B	-1.32B	-4.57B	-3.97B
Net Income Margin	-	-	-	-71.26%	-4.44%	2.05%	-0.97%	-25.11%	-7.43%	-31.60%	-24.82%
R&D	-	-	-	-	440.67M	306.70M	404.56M	450.38M	298.31M	559.98M	943.88M
R&D as % of Total Revenue	-	-	-	-	2.17%	1.34%	1.78%	2.88%	1.68%	3.87%	5.90%
Interest Expense	0	0	0	0	293.92M	495.16M	173.49M	384.49M	613.68M	582.34M	594.16M
Interest Expense % of Total Revenue	-	-	-	0.00%	1.45%	2.16%	0.76%	2.46%	3.45%	4.02%	3.72%

Balance Sheet

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	9.88B	9.92B	9.97B	32.74B	43.14B	50.24B	52.68B	51.28B	50.56B	48.97B	46.39B
Total Liabilities	1.42B	1.46B	1.49B	8.90B	18.95B	9.47B	12.77B	14.95B	15.08B	16.36B	18.13B
Total Equity	8.45B	8.46B	8.48B	23.83B	24.19B	40.77B	39.91B	36.33B	35.48B	32.62B	28.27B
Cash	335.87M	364.03M	411.44M	2.68B	700.01M	5.73B	2.13B	447.75M	953.37M	221.05M	350.62M
Total Debt	1.39B	1.44B	-	5.78B	16.09B	7.17B	-	-	-	-	-
Net Debt	-	-	-	-	-	1.59B	7.42B	12.73B	11.45B	13.91B	15.45B

Cash Flow

Currency: KRW	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-69.90M	-45.15M	1.22B	-701.24M	909.18M	2.27B	-93.32M	1.45B	-2.04B	-1.75B
Investing Cash Flow	0	0	1.51B	-12.80B	-2.93B	-8.06B	-5.09B	-119.25M	-385.63M	-
Financing Cash Flow	-	-	-427.18M	11.52B	7.05B	2.19B	3.50B	-821.19M	1.69B	-
Capital Expenditure	0	0	835.35M	16.32B	3.74B	2.37B	10.03M	113.36M	368.85M	262.43M
Free Cash Flow	-	-	-	-11.23B	-2.83B	-97.92M	-103.35M	1.33B	-2.40B	-2.01B
Dividends Paid	-	-	112.16M	-	-	-	-	-	-	-
FCF to OCF	-	-	-	1601.27%	-311.02%	-4.32%	110.75%	92.16%	118.12%	114.99%

Earnings

Report Date	Mar 31, 2016	Jun 30, 2016	Sep 30, 2016	Dec 31, 2016	Mar 31, 2017	Jun 30, 2017	Sep 30, 2017	Dec 31, 2017	Mar 31, 2018	Jun 30, 2018	Sep 30, 2018	Dec 31, 2018	May 15, 2019	Aug 14, 2019	Nov 14, 2019	Feb 24, 2020	May 15, 2020	Aug 14, 2020	Nov 16, 2020	Feb 8, 2021	May 17, 2021	Aug 17, 2021	Nov 15, 2021	Feb 16, 2022	Mar 31, 2022	Jun 30, 2022	Nov 14, 2022	Feb 13, 2023	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	10.86	10.86	-0.50	1.63	8.22	-23.15	7.43	23.24	10.70	72.88	-3914.63	59.01	6.01	6.67	-10.48	-42.86	18.09	9.52	-8.60	1.45	1.00	4.00	-15.00	1.72	-7.15	-86.11	-35.87	-86.22	-3.48	28.46	-91.56	-170.09	-92.55	-221.00	-170.36	-336.06	-147.80	-172.75	-182.07	-208.85	-149.56	-135.72
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	After-hours	Pre-market	Pre-market	-	-	-	-	Pre-market	After-hours	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap3.89B

Enterprise Value22.42B

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.23

Price / Book0.15

Revenue (TTM)16.98B

Gross Profit (TTM)3.78B

EBITDA-2.70B

Profit Margin-22.22%

Operating Margin-19.93%

Return on Equity-13.12%

Return on Assets-4.71%

Shares Outstanding5.58M

Shares Float2.36M

Beta-0.78

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

May 19, 20261:5
Oct 16, 2020842:801